Nodenza Venture Partners to Present at the 1FinanceWorld Global Finance Conference
- Article
- May 20, 2024
- 1 Min Read
Written By Nodenza
New York, May 20, 2024 – Nodenza Ventures Partners’ (“Nodenza”) Ross Morton, Managing Partner will be presenting at the 1FinanceWorld Global Finance Conference on May 22-24, 2024. He will be discussing “The Graveyard of Biotech” bridging the gap between venture capital and private equity to support late-stage biotech and medical device products.
To find out more about how we can partner with you to fund, advise and support growing healthcare companies, please reach out to us to schedule a meeting.
Contacts
Nodenza Venture Partner
Mo Advisory PR
Notes For Editors
About Nodenza Venture Partners
Nodenza Venture Partners invests globally in early-stage and pre-commercial companies and products designed to bring exceptional patient benefit. Our bi-modal investment strategy combines early-stage opportunities – advancing new treatment modalities through active IND to phase 2 – with pre-commercial targets supporting their transition from scientific to commercial companies delivering strong upside potential. Established by a team of experienced life sciences entrepreneurs, founders and leaders, our approach leverages Nodenza’s extensive expertise in the creation and growth of new companies, as well as late-stage product development and launch.
